Grip Strength as a Mortality Biomarker: What the PURE Cohort Showed

Educational journalism, not medical advice. Every claim here is checked against its cited sources by editor Tim Bunce — a health writer, not a physician. It isn’t specific to your situation: for health decisions, talk to your own clinician. How we work →

The mortality data

The strongest single dataset is the PURE cohort — nearly 140,000 adults across 17 countries, followed for 4 years. The findings:

• Each 5 kg lower grip strength was associated with 16% higher all-cause mortality, 17% higher cardiovascular mortality, and 9% higher cancer mortality.
• The relationship held after adjustment for age, sex, education, employment, smoking, drinking, exercise, and country.
• Grip was a better predictor of all-cause mortality than systolic blood pressure — meaning a poor grip is worse news than hypertension, statistically Leong 2015.

Follow-up data from PURE and from independent cohorts (UK Biobank, NHANES) has consistently replicated the finding. The dose-response curve is roughly linear — there’s no single “cliff” threshold; lower grip is uniformly worse Celis-Morales 2018.

“Grip strength is a better predictor of all-cause mortality than systolic blood pressure. The association is graded, dose-dependent, and persists after adjustment for major covariates. Grip strength deserves consideration as a routine clinical biomarker.”

— Leong et al., Lancet, 2015 view source

Why grip predicts so much

Grip isn’t magical — it’s a proxy for several underlying capacities that all matter for health:

• Skeletal muscle mass and quality. Forearm strength tracks with whole-body muscle mass and with muscle protein turnover.
• Neurological function. Producing a maximal grip requires intact motor units, peripheral nerves, and central drive. Decline often shows up first in grip before other measures.
• Cardiovascular reserve. Maximal grip briefly raises blood pressure and heart rate; the response correlates with cardiovascular fitness.
• Metabolic health. Grip is inversely correlated with HbA1c, insulin resistance, and inflammatory markers in cross-sectional studies.
• Frailty and falls risk. Adults with weak grip have higher fall rates, more fractures, and worse post-surgical outcomes.

What “weak grip” means

The clinical thresholds for sarcopenia (age- and sex-adjusted):

• Adult men: <26-27 kg suggests reduced muscular function; <20 kg meets clinical sarcopenia threshold.
• Adult women: <16-17 kg suggests reduced function; <12-13 kg meets clinical threshold.
• These are minimums. Healthy adults typically register 35-50 kg (women) and 50-70+ kg (men). Elite athletes substantially higher.
• Test with a hand dynamometer: available in most physiotherapy offices, gyms, and as inexpensive home devices ($30-100).

Grip is trainable

Unlike some biomarkers (chronological age, genetic markers), grip strength responds to training:

• Farmer’s carries — walking with heavy weights in each hand — produce the largest grip gains per unit time. 2-3 sets weekly of 20-30 m carries with progressively heavier weights.
• Dead hangs from a pull-up bar — pure isometric grip endurance. Build to 60-second holds.
• Heavy deadlifts without straps train grip directly through the pull. Most adults plateau in grip before their hip-extension strength does, providing a natural training stimulus.
• Hand grippers — cheap dedicated devices — produce modest gains. Less effective than loaded carries per unit time but convenient.
• Avoid lifting straps for sets where grip isn’t the limiting factor — straps offload the forearms and reduce the grip training stimulus.

Is the effect causal?

The big remaining question in grip-mortality research is whether improving grip improves outcomes, or whether grip is just a marker of something else that improves outcomes. The trial evidence is suggestive but not definitive:

• Resistance-training interventions in older adults improve both grip and clinical outcomes (falls, fractures, mortality).
• Improvements in grip predict improvements in functional capacity at the individual level.
• The mechanism (whole-body muscle function) is plausible.

The current clinical consensus: train grip as part of general resistance training, not because grip-training in isolation extends life, but because the underlying capacity it reflects matters Celis-Morales 2018.

Practical takeaways

• Grip strength is one of the best-validated mortality biomarkers in clinical medicine. Each 5 kg reduction is associated with 16% higher all-cause mortality.
• Grip is a proxy for skeletal muscle function, neurological status, cardiovascular reserve, and metabolic health — not a single isolated capacity.
• Test with a hand dynamometer. Clinical sarcopenia thresholds: <20 kg (men), <13 kg (women).
• Grip is trainable: farmer’s carries, dead hangs, heavy deadlifts without straps, hand grippers. 2-3 sessions weekly.
• Effect appears causal (training improves outcomes), but the practical answer is the same regardless: build grip as part of general resistance training.

How to measure grip so the number means something

The mortality thresholds are only as trustworthy as the way grip is measured. A reading taken standing up, with a cheap squeeze-ball gadget, on a single half-hearted try is not the same measurement researchers used — and comparing it to a clinical cut-off is meaningless. The reference standard comes from a 2011 review by Roberts and colleagues, which proposed what is now called the "Southampton protocol" to bring consistency to a field where studies varied so much that their results could not be compared Roberts 2011.

The core of the protocol is simple. Use a hydraulic Jamar-style dynamometer — the most widely used instrument, with established test-retest, inter-rater and intra-rater reliability — rather than a spring or pinch gauge. Sit in a standard chair with back and arm support, shoulder relaxed and adducted, elbow bent at 90 degrees, forearm and wrist in a neutral position with the thumb pointing up. Take three measurements on each hand, alternating sides, with brief rest between, and record the single highest of the six as your result Roberts 2011. Roberts and colleagues note that the Jamar requires calibration at least annually, because an uncalibrated device drifts and quietly invalidates everything you read off it Roberts 2011.

Two practical points follow. First, posture changes the number — measuring while standing, or with the elbow straight, generally produces different readings, so always test the same way if you want to track change over time. Second, the headline cut-offs in this article come from this kind of standardized testing; a number from a fitness-tracker grip ring or a gym gripper toy cannot be plugged into them. If you want a reading you can actually compare to the evidence, ask a physiotherapist or a clinic with a calibrated dynamometer to do it properly.

Beyond death: what else weak grip forecasts

All-cause mortality is the headline, but the same weakness shows up across a long list of specific outcomes — which is part of why researchers treat grip as a window onto whole-body health rather than a hand-strength test. A 2018 meta-analysis by García-Hermoso and colleagues pooled 38 cohort studies and roughly 1.9 million apparently healthy adults and found a consistent inverse relationship: higher muscular strength predicted lower all-cause mortality, and the association held after accounting for age, sex, smoking, body-mass index, physical activity and existing disease García-Hermoso 2018. That breadth of adjustment is what makes the signal hard to dismiss as a fluke of unhealthy lifestyles travelling together.

The most striking non-mortality finding concerns the brain. A 2022 UK Biobank study of 466,788 adults followed for a median of about nine years found that people in the weakest fifth for grip strength had a 72% higher risk of developing dementia than the strongest fifth, and an 87% higher risk of dying from dementia — independent of major confounders Esteban-Cornejo 2022. The authors estimated that roughly 30% of dementia cases and 32% of dementia deaths in the cohort were statistically attributable to low grip strength Esteban-Cornejo 2022. That is an association, not proof that weak hands cause dementia (see the cautions below), but it reinforces grip as a marker of brain as well as body resilience.

A 2022 dose-response meta-analysis by López-Bueno and colleagues — 48 studies and more than 3.1 million participants — also mapped where the risk actually sits across the range. For all-cause mortality, risk fell in a close-to-linear way as grip rose from about 26 up to 50 kg; for cancer death the protective range was roughly 16 to 33 kg, and for cardiovascular death roughly 24 to 40 kg — both lower than the all-cause range López-Bueno 2022. In plain terms: the gains from being stronger are largest for people who start out genuinely weak, and they level off rather than rewarding ever-higher numbers without limit.

Asymmetry, relative strength, and who must read the number carefully

A single peak figure is not the whole story. One refinement is asymmetry — a meaningful difference in strength between your two hands. Researchers commonly define this as one hand more than 10% stronger than the other, and the imbalance may flag neuromuscular problems before maximum strength itself falls Polo-López 2026. A 2026 prospective study across 28 countries (more than 107,000 adults) found a dose-response link: at 10 kg of between-hand asymmetry, all-cause mortality risk was about 32% higher and cardiovascular mortality about 39% higher, with cardiovascular risk climbing further at 15 kg or more Polo-López 2026. A lopsided result, then, is worth noting even when your stronger hand looks fine — though it is a prompt to ask a clinician about, not a diagnosis.

Context also matters for what counts as "weak." The clinical sarcopenia thresholds widely used in older adults come from the 2019 revised European consensus (EWGSOP2), which set low grip strength at below 27 kg for men and below 16 kg for women as the first step toward diagnosing age-related muscle loss Cruz-Jentoft 2019. These are screening cut-offs for older people, not universal pass-fail lines for healthy young adults, and the framework deliberately treats low grip as "probable sarcopenia" that further tests then confirm Cruz-Jentoft 2019.

Some groups should interpret any grip reading with extra care, ideally alongside a clinician. Hand or wrist arthritis, a recent fracture, carpal tunnel syndrome, a stroke affecting one side, or pain on gripping can all depress the number for reasons that have nothing to do with whole-body health or longevity. In those cases a low or asymmetric result reflects the local problem, not your mortality risk, and chasing the grip figure would be the wrong target. Older adults, people recovering from illness, and anyone with a hand condition are exactly the readers for whom grip is most useful as a flag — and most easily misread without professional input.

Myths, limits, and what the evidence does not say

The biggest misconception is that squeezing a hand-gripper will buy you the longevity seen in the studies. It almost certainly will not, for two reasons. First, the association is built on grip as a proxy for overall muscle and health, not on hand strength as a direct cause — improving the proxy without improving the underlying biology is unlikely to transfer. Second, grip is surprisingly stubborn even to real training. A 2019 meta-analysis by Labott and colleagues (24 trials, about 3,000 older adults) found only small improvements in grip strength from exercise overall, and concluded that grip "cannot clearly be recommended" as a yardstick of general training success because whole-body programs often move it very little Labott 2019. In other words, you can get meaningfully fitter and stronger while your grip number barely budges.

What does reliably raise grip is fairly specific, structured resistance training. A 2025 network meta-analysis by Li and colleagues, focused on older adults with sarcopenia, found the largest gains clustered around training roughly three times a week, sustained for several months (around 19 weeks in their model), with a moderate-to-substantial weekly volume Li 2025. The takeaway is not to chase the gripper toy but to do consistent loaded exercise — which is also what improves the muscle mass, function and metabolic health that grip is standing in for.

Finally, the honest caveats. Almost all of this evidence is observational, which means reverse causation is a live problem: undiagnosed early disease, frailty or impending decline can lower grip strength rather than the other way around, so a weak grip is sometimes a symptom of illness already present, not a cause of future death. The dementia and mortality figures are robust associations, but no cohort study can prove that strengthening your grip, by itself, lengthens your life. The defensible reading is the one the wider literature supports: grip is an excellent, cheap, repeatable warning light — and the response to a dim light is to address overall strength, activity and any underlying condition with a clinician, not to fixate on the gauge.

References